Atrial Fibrillation in Active Cancer Patients

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

September 1, 2025

Study Completion Date

January 1, 2026

Conditions
CancerDrug ToxicityAtrial FibrillationCardiovascular Complication
Interventions
OTHER

occurence of atrial fibrillation

all adult patients with an active cancer and experiencing atrial fibrillation will be consecutively include. Active cancers will be defined according Agnelli et al. (NEJM 2020; 382:1599-1607).

Trial Locations (1)

14000

RECRUITING

Alexandre, Caen

All Listed Sponsors
collaborator

University Hospital, Marseille, France

UNKNOWN

collaborator

Hospices Civils de Lyon, France

UNKNOWN

collaborator

Centre Francois Baclesse, Caen, France

UNKNOWN

collaborator

University Hospital of Saint-Etienne, France

UNKNOWN

collaborator

Hôpital Lariboisière Fernand Widal, Paris, France

UNKNOWN

collaborator

Institut de Cancérologie de l'Ouest Nantes, France

UNKNOWN

collaborator

Fundacion Cardio Onco, Santiago, Chile

UNKNOWN

collaborator

Hunter New England Area Health Service, University of Newcastle, Australia

UNKNOWN

collaborator

University Hospital, Rouen

OTHER

lead

University Hospital, Caen

OTHER